The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. That said, here are three stocks where Wall Street may be overlooking some important risks and some alternatives with better fundamentals.
Sportsman's Warehouse (SPWH)
Consensus Price Target: $2.92 (132% implied return)
A go-to destination for individuals passionate about hunting, fishing, camping, hiking, shooting sports, and more, Sportsman's Warehouse (NASDAQ: SPWH) is an American specialty retailer offering a diverse range of active gear, equipment, and apparel.
Why Should You Dump SPWH?
- Lagging same-store sales over the past two years suggest it might have to change its pricing and marketing strategy to stimulate demand
- Performance over the past three years was negatively impacted by new share issuances as its earnings per share dropped by 41.4% annually, worse than its revenue
Sportsman's Warehouse is trading at $1.26 per share, or 17x forward EV-to-EBITDA. To fully understand why you should be careful with SPWH, check out our full research report (it’s free).
Addus HomeCare (ADUS)
Consensus Price Target: $132.69 (36.4% implied return)
Serving approximately 66,000 clients across 22 states with a focus on "dual eligible" Medicare and Medicaid beneficiaries, Addus HomeCare (NASDAQ: ADUS) provides in-home personal care, hospice, and home health services to elderly, chronically ill, and disabled individuals.
Why Are We Wary of ADUS?
- Subscale operations are evident in its revenue base of $1.45 billion, meaning it has fewer distribution channels than its larger rivals
- Stagnant returns on capital show management has failed to improve the company’s business quality
At $97.30 per share, Addus HomeCare trades at 13.6x forward P/E. Read our free research report to see why you should think twice about including ADUS in your portfolio.
Array (AD)
Consensus Price Target: $46.26 (27.6% implied return)
Operating as a majority-owned subsidiary of Telephone and Data Systems since its founding in 1983, Array (NYSE: AD) is a regional wireless telecommunications provider serving 4.6 million customers across 21 states with mobile phone, internet, and IoT services.
Why Do We Avoid AD?
- Sales tumbled by 23.5% annually over the last five years, showing market trends are working against it during this cycle
- 15 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position
- High net-debt-to-EBITDA ratio of 466× increases the risk of forced asset sales or dilutive financing if operational performance weakens
Array’s stock price of $36.25 implies a valuation ratio of 20.5x forward EV-to-EBITDA. If you’re considering AD for your portfolio, see our FREE research report to learn more.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
